"[The study] results may support a paradigm shift towards a biochemistry-first approach rather than imaging-first in the differential diagnostic workup of ACTH-dependent CS [Cushing syndrome], ...
Detailed price information for Crinetics Pharmaceuticals Inc (CRNX-Q) from The Globe and Mail including charting and trades.
PORTLAND, Ore.--(BUSINESS WIRE)--Sparrow Pharmaceuticals, a clinical-stage biopharmaceutical company developing novel, targeted therapies to address unmet needs in both endocrinology and rheumatology, ...
Nat Clin Pract Endocrinol Metab. 2006;2(11):642-647. The presentation of EAS and Cushing's disease can be identical, and because the a priori odds of Cushing's disease are high, severe demands are ...
Hypercortisolism can have variable clinical presentations; low-grade disease may not present with classic signs such as facial plethora, striae, or proximal myopathy. Cushing disease is the most ...
The Nature Index 2026 Research Leaders reveal the leading institutions and countries/territories in the natural sciences, health sciences, applied sciences and social sciences, according to their ...
Initial Data from Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia to be Presented, Along with Initial Findings from Phase 1b/2a ACTH-Dependent Cushing’s Syndrome Trial Data from Phase 3 ...
Cushing disease occurs when benign tumors on the pituitary gland release excess adrenocorticotropic hormone (ACTH), leading to high cortisol levels. Cushing syndrome is the name for the disorder or ...
Oral presentation features open label extension PALSONIFY™ (paltusotine) data, reinforcing its best-in-class potential in acromegaly following recent U.S. and E.U. approvals Two oral presentations of ...
Cushing syndrome is caused by long-term exposure to high cortisol levels. Diagnosing the cause can help determine the type of treatment needed. Lifestyle changes can also help with symptoms. Every ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results